Patients who present with thrombocytopenia, anasarca, fever/elevated C reactive protein (CRP), reticulin fibrosis or renal failure, and organomegaly are defined as iMCD-TAFRO, while those who do not meet these criteria are referred to as iMCD not otherwise specified (iMCD-NOS). This evidence concerns the gene CRP and acute kidney injury.